Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of COVID-19 on diabetes care among dutch diabetes outpatients.
Bak JCG, Serné EH, Groenwold RHH, de Valk HW, Kramer MHH, Nieuwdorp M, Verheugt CL. Bak JCG, et al. Among authors: kramer mhh. Diabetol Metab Syndr. 2023 Oct 10;15(1):193. doi: 10.1186/s13098-023-01169-9. Diabetol Metab Syndr. 2023. PMID: 37817214 Free PMC article.
Renal sinus fat and renal hemodynamics: a cross-sectional analysis.
Spit KA, Muskiet MHA, Tonneijck L, Smits MM, Kramer MHH, Joles JA, de Boer A, van Raalte DH. Spit KA, et al. Among authors: kramer mhh. MAGMA. 2020 Feb;33(1):73-80. doi: 10.1007/s10334-019-00773-z. Epub 2019 Aug 31. MAGMA. 2020. PMID: 31471702 Free PMC article.
Effects of dipeptidyl peptidase-4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis of an 8-week, randomized, controlled, double-blind trial.
Kraaijenhof J, Muskiet MHA, Tonneijck L, Ouwens DM, Kramer MHH, van Raalte DH, Smits MM. Kraaijenhof J, et al. Among authors: kramer mhh. Diabetes Obes Metab. 2020 Oct;22(10):1847-1856. doi: 10.1111/dom.14107. Epub 2020 Jun 22. Diabetes Obes Metab. 2020. PMID: 32476255 Free PMC article. Clinical Trial.
Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial.
Muskiet MHA, Tonneijck L, Smits MM, Kramer MHH, Ouwens DM, Hartmann B, Holst JJ, Touw DJ, Danser AHJ, Joles JA, van Raalte DH. Muskiet MHA, et al. Among authors: kramer mhh. Diabetes Care. 2020 Nov;43(11):2889-2893. doi: 10.2337/dc20-0902. Epub 2020 Sep 8. Diabetes Care. 2020. PMID: 32900785 Clinical Trial.
SGLT2 inhibition versus sulfonylurea treatment effects on electrolyte and acid-base balance: secondary analysis of a clinical trial reaching glycemic equipoise: Tubular effects of SGLT2 inhibition in Type 2 diabetes.
van Bommel EJM, Geurts F, Muskiet MHA, Post A, Bakker SJL, Danser AHJ, Touw DJ, van Berkel M, Kramer MHH, Nieuwdorp M, Ferrannini E, Joles JA, Hoorn EJ, van Raalte DH. van Bommel EJM, et al. Among authors: kramer mhh. Clin Sci (Lond). 2020 Dec 11;134(23):3107-3118. doi: 10.1042/CS20201274. Clin Sci (Lond). 2020. PMID: 33205810 Clinical Trial.
Combination therapy with exenatide decreases the dapagliflozin-induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes: A randomized controlled trial.
van Ruiten CC, Veltman DJ, Wijdeveld M, Ten Kulve JS, Kramer MHH, Nieuwdorp M, IJzerman RG. van Ruiten CC, et al. Among authors: kramer mhh. Diabetes Obes Metab. 2022 Aug;24(8):1588-1597. doi: 10.1111/dom.14732. Epub 2022 May 23. Diabetes Obes Metab. 2022. PMID: 35491524 Free PMC article. Clinical Trial.
160 results